FDA Reverses Stance on Leucovorin for Autism



(MedPage Today) — The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday.
Leucovorin is…



Source link : https://www.medpagetoday.com/neurology/autism/120245

Author :

Publish date : 2026-03-10 21:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version